Showing 1 - 3 results of 3 for search 'Mark Fereshteh', query time: 0.02s Refine Results
  1. 1
    80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC)

    80 Association of in situ T-cell receptor diversity and tumor adjacent immune cells to checkpoint inhibitor response in head and neck squamous cell carcinoma (HNSCC) by Matthew Loya, Homer Adams, Omar Jabado, Patrick Franken, Nora Pencheva, Mark Fereshteh, Li Fan, Anantharaman Muthuswamy, Angelo Harris, Susan Sun, Gabrielle Suppa

    Published 2023-11-01
    Article
  2. 2
    562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer

    562 Combined spatial and transcriptomic analysis identifies immune microenvironment factors associated with checkpoint inhibition response in triple negative breast cancer by Wei Han, Matthew Loya, Omar Jabado, Patrick Franken, Nora Pencheva, Mark Fereshteh, Chung-Wein Lee, Clifton Drew, Louise Koopman, Angelo Harris, Mohammed Qutaish, Brooke Robertson

    Published 2023-11-01
    Article
  3. 3
    DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity

    DuoBody-CD40x4-1BB induces dendritic-cell maturation and enhances T-cell activation through conditional CD40 and 4-1BB agonist activity by Maria Jure-Kunkel, Homer C Adams III, Kate Sasser, Mark Fereshteh, Alexander Muik, Isil Altintas, Friederike Gieseke, Aras Toker, Özlem Türeci, Tahamtan Ahmadi, Ugur Sahin, Dennis Verzijl, Kristina B Schoedel, Jordan M Blum, Bianca Sänger, Saskia M Burm, Eliana Stanganello, Vanessa M Spires, Fulvia Vascotto, Juliane Quinkhardt, Mustafa Diken, David P E Satijn, Sebastian Kreiter, Esther C W Breij

    Published 2022-06-01
    Get full text
    Article

Search Tools: